CN1151814C - Composite Chinese medicine for treating rheumatic Bi syndrome - Google Patents
Composite Chinese medicine for treating rheumatic Bi syndrome Download PDFInfo
- Publication number
- CN1151814C CN1151814C CNB011098295A CN01109829A CN1151814C CN 1151814 C CN1151814 C CN 1151814C CN B011098295 A CNB011098295 A CN B011098295A CN 01109829 A CN01109829 A CN 01109829A CN 1151814 C CN1151814 C CN 1151814C
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- chinese medicine
- rheumatic
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a traditional Chinese medicine for treating rheumatism, which comprises safflower, slenderstyle acanthopanax bark, clematis root, incised notoptetygium rhizome or root, doubleteeth pubesscent angelica root, tall gastrodis tuber, ledebouriella root, giant typhonium rhizome, largehead atractylodes rhizome, frankincense and angelica. The present invention can effectively treat various rheumatism diseases, such as rheumarthritis, rheumatoid arthritis, rheumatic myalgia, periarthritis humeroscapularis, lumbar disc protrusion, hyperosteogeny, sciatica, pain of the whole body caused by postpartum wind receiving of women, etc.
Description
The present invention relates to a kind of Chinese medicine composition for the treatment of rheumatic Bi syndrome, have the effect of expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation, dredge the meridian passage, dispersing cold for relieving pain.
The arthromyodynia of Chinese medicine refers to exopathogen invasion and attack human bodies such as all because wind, cold, wet, heat, the impatency meridians, even QI-blood circulation due to smooth with muscle, muscles and bones, arthralgia, numbness weighing, the joint stuffiness arthroncus is scorching hot etc. is the disease of main clinical manifestation.Based on wind, cold, wet and rheumatic Bi syndrome that cause is more common.Mainly comprise various diseases such as whole body pain due to the rheumatic arthritis, rheumatoid arthritis, rheumatic myalgia, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, women's puerperal exposure to wind of modern medicine indication.
These diseases belong to commonly encountered diseases and frequently-occurring disease, and delay is difficult, meet inducement and are easy to recurrence, have a strong impact on people's work and life.Doctor trained in Western medicine does not have effect method, and the traditional Chinese medical science is in expelling wind and cold, eliminating dampness and dredging channels, and in addition blood-activating and qi-promoting is transferred the human righteousness, often can obtain effect preferably.
Purpose of the present invention just provides a kind of Chinese medicine composition, can effectively treat the various diseases that belong to rheumatic Bi syndrome such as whole body pain due to rheumatic arthritis, rheumatoid arthritis, rheumatic myalgia, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, the women's puerperal exposure to wind.
Chinese medicine composition of the present invention contains Flos Carthami, Cortex Acanthopancis, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Rhizoma Gastrodiae, Radix Saposhnikoviae, Rhizoma Typhonii, the Rhizoma Atractylodis Macrocephalae, Olibanum, Radix Angelicae Sinensis, wherein the common ratio of each component is Flos Carthami 5-10, Cortex Acanthopancis 12-18, Radix Clematidis 9-15, Rhizoma Et Radix Notopterygii 6-12, Radix Angelicae Pubescentis 6-12, Rhizoma Gastrodiae 3-9, Radix Saposhnikoviae 6-12, Rhizoma Typhonii 3-5, Rhizoma Atractylodis Macrocephalae 12-18, Olibanum 6-12, Radix Angelicae Sinensis 6-12.In clinical use, can suitably adjust the wherein consumption of each component according to the concrete state of an illness.The preferred group of this compositions becomes Flos Carthami 8, Cortex Acanthopancis 15, Radix Clematidis 12, Rhizoma Et Radix Notopterygii 9, Radix Angelicae Pubescentis 9, Rhizoma Gastrodiae 6, Radix Saposhnikoviae 10, Rhizoma Typhonii 3, the Rhizoma Atractylodis Macrocephalae 15, Olibanum 9, Radix Angelicae Sinensis 10.The effect of each component in compositions is:
Radix Angelicae Sinensis, Flos Carthami, Olibanum promoting blood circulation to remove obstruction in the collateral, the circulation of qi promoting of enriching blood, antalgic; Cortex Acanthopancis, Radix Clematidis, Rhizoma Et Radix Notopterygii rouse oneself yang-energy, expelling wind and removing dampness, analgesia bone strengthening; Rhizoma Gastrodiae, Radix Saposhnikoviae, Rhizoma Typhonii wind dispelling collateral dredging relieving convulsion, the dehumidifying analgesia; Rhizoma Atractylodis Macrocephalae invigorating the spleen and replenishing QI, the dampness inducing diuresis to remove edema.
Chinese medicine composition of the present invention can be made any pharmaceutical dosage form that is suitable for clinical practice by process of Chinese medicine preparation routinely, and as pill, powder, tablet, oral liquid, electuary, plaster, medicated bag etc., preferred dosage form is a capsule.The preparation technology of capsule is: with each raw medicinal material high-temperature sterilization, pulverize, incapsulate.
Compositions of the present invention is made capsule, the treatment rheumatic Bi syndrome, comprise with various diseases such as whole body pain due to muscle, muscles and bones, arthralgia, miserable, numbness is weighing, joint stuffiness etc. is main clinical manifestation rheumatic arthritis, rheumatoid arthritis, rheumatic myalgia, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, the women's puerperal exposure to wind, through clinical use for many years, can effectively eliminate clinical symptoms, curative effect is reliable, and late result is good, and relapse rate is low.Except that anemia of pregnant woman Ying Shen uses, have no side effect.Below be that clinical observation is summed up:
One, this medicine of physical data is made use for many years by oneself, begins small lot batch manufacture after 98 years, and one band uses in Jilin as inner preparation, and has part to sell to Korea S and Korea.The thousands of at least people of user, minimum tens years old, maximum 80 years old.Now collecting 300 examples and added up than the case of system, is the object of observation with the outpatient that grows up, and based on rheumatic arthritis and rheumatoid arthritis, the invasion and attack history of wind-cold damp pathogen is arranged more.
Two, diagnostic criteria muscle, muscles and bones, joint aches, numbness are weighing or pain, joint stuffiness, and joint deadlock in morning is met cold then heavyly, and De Rede is by alleviating visible arthroncus when serious.
Lab index such as clinical discovery erythrocyte sedimentation rate, anti-" O ", rheumatoid factor do not have specificity for diagnosticating rheumatic arthritis and rheumatoid arthritis, therefore only as a reference with these indexs, not with it as diagnosis and efficacy assessment standard.
Three, Therapeutic Method is taken the capsule of the application's pharmaceutical composition, and every contains medicine 0.2 gram, and every day 3 times, each 3, take 20-30 minute ante cibum.Each month is a course of treatment, generally takes 2-3 the course of treatment.
Four, efficacy assessment standard adopts self treatment front and back symptom contrast, and observation item is
The pain in joint and numbness are weighing to be felt
Whether the limbs joint activity is limited
Have or not the deadlock in morning
Original arthroncus degree change
More than every symptom no change be invalid, alleviate to effectively, disappearing is to cure.
Five, generally after the treatment of a course of treatment, the most patients sensory symptoms alleviates therapeutic outcome, through 2-3 the course of treatment, transference cure.Recovery from illness accounts for 65%, effective 22%, invalid 13% by statistics.After this Drug therapy, inducements such as most patients chance cold-damp no longer recur.
Model case
1, Lee man, 68 years old, be engaged in motor vehicle repair for a long time, suffered from arthritis from 68 years, increase the weight of year by year, go to a doctor in many ways, bad during fashion.Handicapped since 99 years, pain unbearably, biped feels cold, also will wear woolen stockings summer.In January, 2000, the application's medicine was taken in prescription on individual diagnosis, and pain alleviates gradually, and the arch of the foot heating can trot out to May in the same year, and freedom of movement does not have outbreak so far, walking every day 1 hour.
2, Ms Zhang, 40 years old, in October, 99 unexpected limb edema, pain, joint motion is limited, can not descend ground, through hospital diagnosis is acute rheumatic arthritis, took this medicine 7 days, pain relief, swelling alleviates after 15 days, can walk about down, recover normal after 30 days, continue to take medicine one month, so far not recurrence to consolidate curative effect.
3, Mrs Gao, 20 years old, often feel legs and feet arthralgia since the childhood, meet overcast and rainy increasing the weight of, can not squat down difficulty in walking when serious.Be arthritis after diagnosing, the IgG positive, erythrocyte sedimentation rate is accelerated, and once takes multiple Chinese and western drugs, and is bad during fashion.99 years begin to take this medicine, back sense in the preceding 3 days joint heating of taking medicine, and pain increases the weight of, and takes 15 days pain reliefs, takes continuously 40 days, and pain disappears, and is movable normal, turning out cloudy property of IgG, erythrocyte sedimentation rate is normal.
4, Mr. Li, 65 years old, arm can not be lifted high and crooked backward, limitation of activity, the difficulty of wearing the clothes, numbness of the fingers, the difficulty of squatting down, ridge is stiff, is diagnosed as arthritis and scapulohumeral periarthritis, and hyperosteogeny is arranged.Begin to take this medicine in January, 99, took continuously 3 months, and arm is movable normal, and numb stiff sense disappears, and idol has pain, but obviously alleviates.
Claims (4)
1, a kind of Chinese medicine composition for the treatment of rheumatic Bi syndrome is characterized in that being made by following materials of weight proportions: Flos Carthami 5-10, Cortex Acanthopancis 12-18, Radix Clematidis 9-15, Rhizoma Et Radix Notopterygii 6-12, Radix Angelicae Pubescentis 6-12, Rhizoma Gastrodiae 3-9, Radix Saposhnikoviae 6-12, Rhizoma Typhonii 3-5, Rhizoma Atractylodis Macrocephalae 12-18, Olibanum 6-12, Radix Angelicae Sinensis 6-12.
2, Chinese medicine composition according to claim 1, the weight proportion that it is characterized in that each raw material is a Flos Carthami 8, Cortex Acanthopancis 15, Radix Clematidis 12, Rhizoma Et Radix Notopterygii 9, Radix Angelicae Pubescentis 9, Rhizoma Gastrodiae 6, Radix Saposhnikoviae 10, Rhizoma Typhonii 3, the Rhizoma Atractylodis Macrocephalae 15, Olibanum 9, Radix Angelicae Sinensis 10.
3, Chinese medicine composition according to claim 1 and 2 is characterized in that being capsule formulation.
4, the purposes of Chinese medicine composition according to claim 1 and 2 in the medicine of whole body painful diseases due to preparation treatment rheumatic arthritis, rheumatoid arthritis, rheumatic myalgia, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, the women's puerperal exposure to wind.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011098295A CN1151814C (en) | 2001-03-20 | 2001-03-20 | Composite Chinese medicine for treating rheumatic Bi syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011098295A CN1151814C (en) | 2001-03-20 | 2001-03-20 | Composite Chinese medicine for treating rheumatic Bi syndrome |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1375311A CN1375311A (en) | 2002-10-23 |
CN1151814C true CN1151814C (en) | 2004-06-02 |
Family
ID=4658159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011098295A Expired - Fee Related CN1151814C (en) | 2001-03-20 | 2001-03-20 | Composite Chinese medicine for treating rheumatic Bi syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1151814C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100427132C (en) * | 2006-09-07 | 2008-10-22 | 张贵 | Traditional Chinese medicine for treating rheumatism and its preparing process |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103356941A (en) * | 2013-08-02 | 2013-10-23 | 欧存仁 | Health-care medicinal liquor having a plurality of functions |
CN105878959A (en) * | 2014-12-15 | 2016-08-24 | 谢海雄 | Knee protection medicine bag for treating wandering arthritis and preparation method |
CN106309530A (en) * | 2016-09-22 | 2017-01-11 | 毛里夏里甫·哈帕 | Medicine for treating rheumatoid arthritis, scapulohumeral periarthritis and cervical spondylosis and preparation and use methods |
CN107823454A (en) * | 2017-11-02 | 2018-03-23 | 张炳炎 | A kind of Dahurian angelica root collaterals-dredgingdrink powder |
CN114042113A (en) * | 2021-11-29 | 2022-02-15 | 儋州市中等职业技术学校 | Traditional Chinese medicine composition for treating rheumatic arthritis and rheumatoid arthritis and application |
-
2001
- 2001-03-20 CN CNB011098295A patent/CN1151814C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100427132C (en) * | 2006-09-07 | 2008-10-22 | 张贵 | Traditional Chinese medicine for treating rheumatism and its preparing process |
Also Published As
Publication number | Publication date |
---|---|
CN1375311A (en) | 2002-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102670979A (en) | Osteopathic medicinal wine for treating rheumatism and preparation process thereof | |
CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
CN100528194C (en) | Medicine for treating femoral head necrosis | |
CN102327479A (en) | Plaster for treating hyperosteogeny, rheumatism, rheumatoid arthritis and arthritis | |
CN102293853B (en) | Chinese medicinal pills for treating Bi syndrome | |
CN1151814C (en) | Composite Chinese medicine for treating rheumatic Bi syndrome | |
CN102872282B (en) | Han Shi Bi Ting Wan for treating ankylosing spondylitis | |
CN104000890B (en) | Traditional Chinese medicine for harmonizing liver and spleen, dispelling wind and eliminating dampness and nourishing blood and stopping throat pains | |
CN1843421A (en) | Rheumatoid disease treating medicine | |
CN102240351B (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
CN1309406C (en) | Medicinal preparation for treating rheumatism and rheumatoid diseases | |
CN102600251B (en) | Rheumatism-rehabilitating traditional Chinese formulation | |
CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN102499964B (en) | A traditional Chinese medicinal preparation for treating necrosis of femoral head | |
CN102048878A (en) | Plaster for assisting in treating rheumatic arthralgia and preparation method thereof | |
CN100427132C (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
CN101380425B (en) | Arthrosis pill | |
CN101194985B (en) | Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny | |
CN101623460B (en) | Medicine for treating rheumatic pain and preparation method thereof | |
CN102755487A (en) | Traditional Chinese medicine powder for eliminating dampness and invigorating blood circulation | |
CN102872252A (en) | Medicinal composition for treating rheumatic pain | |
CN1342478A (en) | Medical wine for treating rheumatism | |
CN1325103C (en) | Tendon and bone strengthening capsule | |
CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040602 |